|
HS Code |
785697 |
| Iupac Name | imidazo[1,2-a]pyridine-6-carboxylic acid |
| Molecular Formula | C8H6N2O2 |
| Molecular Weight | 162.15 |
| Cas Number | 35435-12-4 |
| Appearance | White to off-white powder |
| Melting Point | 292-295 °C |
| Solubility In Water | Slightly soluble |
| Boiling Point | Decomposes before boiling |
| Smiles | C1=CC2=NC=CN2C=C1C(=O)O |
| Inchi | InChI=1S/C8H6N2O2/c11-8(12)6-2-1-3-10-7(6)4-5-9-10/h1-5H,(H,11,12) |
As an accredited H-imidazo[1,2-a]pyridine-6-carboxylic acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The product is packaged in a 25g amber glass bottle with a screw cap, labeled with chemical name, formula, and hazard symbols. |
| Container Loading (20′ FCL) | 20′ FCL: Typically loaded in 25 kg fiber drums, totaling 8–10 MT per container, suitable for efficient bulk transport. |
| Shipping | **H-imidazo[1,2-a]pyridine-6-carboxylic acid** is shipped in tightly sealed containers, protected from moisture and light. It should be handled according to standard chemical safety protocols, including labeling and documentation. The package complies with regulations for chemical transport and may require temperature control if specified by the manufacturer or SDS guidelines. |
| Storage | H-imidazo[1,2-a]pyridine-6-carboxylic acid should be stored in a tightly closed container, in a cool, dry, and well-ventilated area, away from direct sunlight, moisture, and incompatible substances such as strong oxidizing agents. Keep at room temperature, and avoid extreme temperatures. Store according to standard chemical storage guidelines, and ensure proper labeling and secondary containment as needed. |
| Shelf Life | H-imidazo[1,2-a]pyridine-6-carboxylic acid typically has a shelf life of 2–3 years when stored in cool, dry conditions. |
|
Purity 98%: H-imidazo[1,2-a]pyridine-6-carboxylic acid with purity 98% is used in pharmaceutical intermediate synthesis, where high chemical purity ensures reproducible reaction yields. Melting point 250°C: H-imidazo[1,2-a]pyridine-6-carboxylic acid with melting point 250°C is used in solid-state stability studies, where its high thermal stability allows for robust compound performance under elevated temperatures. Molecular weight 174.16 g/mol: H-imidazo[1,2-a]pyridine-6-carboxylic acid at molecular weight 174.16 g/mol is used in drug discovery screening, where its precise molecular mass facilitates accurate dose calculations in assays. Particle size <20 µm: H-imidazo[1,2-a]pyridine-6-carboxylic acid with particle size less than 20 µm is used in formulation development, where uniform small particles enhance dissolution rates. Solubility 10 mg/mL in DMSO: H-imidazo[1,2-a]pyridine-6-carboxylic acid with solubility 10 mg/mL in DMSO is used in high-throughput screening, where optimal solubility ensures consistent compound delivery. Stability temperature up to 60°C: H-imidazo[1,2-a]pyridine-6-carboxylic acid stable up to 60°C is used in accelerated stability studies, where reliable compound integrity is maintained during thermal stress testing. |
Competitive H-imidazo[1,2-a]pyridine-6-carboxylic acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every day in the lab, complex problems demand more than routine solutions. H-imidazo[1,2-a]pyridine-6-carboxylic acid has earned frequent selection for its adaptability and clear value across research and synthesis environments. Decades of applied chemical process development have guided our manufacturing approach, focusing on purity, stability, and ease of downstream application. Drawing on repeated feedback and confirmed analytical results, the material we deliver rarely lands in any bottle as a generic intermediate; it arrives prepared for ambitious projects in modern research and high-value manufacturing.
The core structure of H-imidazo[1,2-a]pyridine-6-carboxylic acid sets it apart from more common aromatic carboxylic acids. Sitting at the intersection of imidazole and pyridine chemistry, the molecule offers reactivity sites that enable transformations in specialized pharmaceutical scaffolds, agrochemical leads, and functional advanced materials. Instead of routine benzoic acid derivatives, this heterocycle opens access to positions not easily reached through traditional syntheses. Many researchers have found that the additional nitrogen and fused ring system serve as both electronic and steric modifiers, supporting more targeted design of final compounds.
The process of scaling up H-imidazo[1,2-a]pyridine-6-carboxylic acid production demands diligence. What works on a test-tube scale may falter when kilo quantities enter the reactor. We maintain purity above 98%, verified by HPLC and NMR, not just as an analytical checkbox—but because sub-parts-per-thousand contamination in this scaffold can derail synthesis downstream. Moisture content is another touchpoint. Trace water can trigger byproducts, so samples ship dry, sealed under inert gas. We know that shelf stability is critical, particularly for customers running longer synthetic timelines, so packaging reflects careful control at every step.
Synthesis of H-imidazo[1,2-a]pyridine-6-carboxylic acid follows a path forged by practical industry problem-solving. Advances in catalytic hydrogenation and cleanup have minimized exposure to problematic residues. Early batches sometimes suffered from residual palladium, so we invested in chromatography upgrades to slash metal content below critical thresholds. We test each batch using validated methods—proton and carbon NMR, melting point assessment, HRMS, and sometimes XRD—to build a chain of evidence for each lot leaving our site. Each run provides new data—observations on color, solubility, and reaction yield. Teams gather weekly, documenting tweaks, anticipating customer feedback, and updating SOPs to reinforce what’s proven effective.
Most customers reach out with specific contexts in mind. Medicinal chemists leverage the structure in small-molecule development, exploring modifications at the 6-carboxyl and ring nitrogen positions. Some teams focus on enzyme inhibitors, others on candidates for CNS-active compounds—our conversations often revolve around substituent compatibility, coupling reactions, and solvent choices. Customization requests come frequently: micro-scale for rapid analog generation, larger volumes for pilot lots, or tweaked crystallization protocols to improve isolation.
On the process chemistry side, feedback about solubility in various polar and nonpolar solvents has led to thinnest possible particle sizing and optimized flow through standard filtration setups. Customers pursuing solid-phase peptide synthesis receive material that’s rigorously dried and sieved, allowing direct charging to their resin beds. Synthetic chemists value our openness to challenge; we adjust production parameters collaboratively, ensuring the acid survives tough coupling and derivatization protocols. Clients have reported improved yields in Suzuki–Miyaura and Buchwald–Hartwig couplings when using our higher-purity substrate, showing that small improvements in input quality can transform downstream efficiency.
Classical benzoic or nicotinic acids, despite their well-known profiles, frequently lack the precision needed in some contemporary targets. In contrast, H-imidazo[1,2-a]pyridine-6-carboxylic acid brings both functional diversity and defined electronic influence to new syntheses. Its nitrogen architecture provides chelating properties absent in simple arenes.
Compared to other imidazopyridine isomers or homologues, the unique arrangement here promotes reactivity at specific positions, streamlining route planning and side-step protection/deprotection requirements found elsewhere. We collaborated last year with a team seeking kinase inhibitor candidates; the results showed significantly fewer process impurities and heightened assay selectivity with this scaffold versus their previous toolkit. These aren’t isolated anecdotes—they reflect a pattern recognizable to practitioners repeatedly seeking more nuanced heterocyclic agents.
Supply chain disruptions can halt discovery and development programs. Manufacturers that treat specialty chemicals as a sideline never invest in robust logistics. Here, dual-path production and batch reservation have blocked material shortfalls. Raw material inspection extends to each batch of starting heterocycles, and we maintain in-house reserves of precursors to ride out market volatility. Each shipment’s trail links raw sources, process data, QC documentation, and finished lot records. Customers auditing our facility routinely report higher confidence, knowing that every drum and sample vial references a complete, transparent record.
Regulations do more than check boxes. Waste handling receives attention from the outset—solvent reduction protocols recycle usable fractions, and spent catalysts get processed through accredited metal recovery programs. We upgraded ventilation and containment in synthesis labs to curb fugitive emissions, both for lab worker health and neighborhood air quality. Our continuous improvement teams document near misses and small incidents, using direct lessons to refine personal protective protocols and process containment.
Workers handling the acid participate in ongoing health surveillance and training. We maintain open channels for issue reporting, treating every suggestion as a jumping-off point for improvement. Third-party audits and community engagement sessions inform our approach, backing up claims with transparent reporting. Our compliance team interprets not just local and regional ordinances but also the spirit of global chemical stewardship.
A strict documentation loop brings each batch of H-imidazo[1,2-a]pyridine-6-carboxylic acid through multiple sign-offs. Each operator logs process deviations, and QC retains reference spectra for routine comparison. Years of running in full campaigns have demonstrated the risks—reactivity issues, yield drops, and hard-to-trace impurities all become known enemies. We learned through a tough recall event, early in our scale-up history, how overlooked details can snowball in finished goods. Post-campaign reviews harvest hard incidents and near-misses, cycling updates back into production and documentation. This loop prevents drift from best practices and supports long-term supply contracts.
We thrive on two-way conversations. Many synthetic routes emerge in partnership, and complex troubleshooting turns up fresh insights. Tried-and-true phone and digital channels give researchers direct access to our chemists—no impersonal customer service barriers. Requests for spectral data, impurity profiles, handling advice, or regulatory documentation rarely wait for more than a shift.
In a recent project, a medicinal chemistry team found that small shifts in drying temperature during material shipment led to subtle but significant changes in crystallinity. Together, we adjusted protocols, performed side-by-side stability studies, and built a shared knowledge file to benefit future shipments. These efforts don’t halt at project completion; aggregated results loop into updated SOPs and product information, constantly raising the baseline for every customer interaction.
Academic groups and industrial discovery teams find value not just in the molecule itself, but in the consistent supply and adaptability of our process. Whether a collaborator requested sub-gram scale for a mechanistic probe or kilogram lots for scale-up, informed feedback looped into every production batch. Rapid prototyping of synthetic approaches—such as functionalization at the carboxyl group followed by ring closure or heteroatom substitution—remains feasible thanks to the scaffold’s robust stability and clean reactivity. Our direct experience with a wide range of derivatization techniques—amidation, esterification, radical substitution—brings extra confidence to those building diverse chemical libraries.
We recognize where this product fits and where it doesn’t: some routes require alternative ring systems or higher functional group density, and we maintain an honest dialogue about those boundaries. Our knowledge pool grows through regular literature reviews, participation in technical consortia, and a steady intake of real-world problem-solving with both established and first-time purchasers.
No specialty chemical process runs without adversity. Scale-up introduced issues like solid formation in transfer lines and batch-to-batch color shifts tied to subtle solvent differences. We incorporated in-line monitoring for turbidity, added specific drying steps, and updated reactor cleaning routines—simple changes that cut downtime and reduced rejects. One unexpected challenge came from packaging compatibility; early shipments developed static, attracting dust and humidity. By trialing different liners and antistatic treatments, we stabilized the environment for transport and storage, delivering product as dry as the day it left our filling lines.
Purification tackled the challenge posed by related ring systems that created closely eluting impurities on silica columns. A committed team tested several chromatographic resins and pH control strategies, ultimately switching to a tailored precipitation step. Further, we found that careful control of recrystallization solvent mixtures eliminated forms unsuitable for direct use in finely-tuned pharmaceutical synthesis.
H-imidazo[1,2-a]pyridine-6-carboxylic acid may occupy a specialized segment of the chemical sector, yet the combined effort poured into each batch reflects decades of accumulated learning. We continually invest in greener protocols—reducing waste, reclaiming solvents, and minimizing energy inputs wherever possible. Efforts to improve atom economy and use less hazardous reagents mesh with customer interest in sustainable chemistry. Regular audits identify areas for further improvement, and new ideas often surface from young team members seeking to bring fresh eyes to longstanding challenges.
Engagement with universities and research hubs fosters exchange—not just of product samples, but of know-how, troubleshooting tricks, and eagerly shared standard procedures. We rotate staff through technical symposia and industry forums, not only to display finished products, but to gather perspectives from peers and thought leaders shaping tomorrow’s chemical innovations.
Anyone can repeat a known reaction. The crucial difference lies in anticipating obstacles, interpreting subtle variances batch-on-batch, and delivering materials with the dependability to back up your next breakthrough. This includes a willingness to pivot production schedules to meet urgent research deadlines, invest in expanded capacity to avoid bottlenecks, and continually revalidate processes to match the pace of regulatory and scientific change.
Customer feedback prompted us to explore single-use reactors and implement remote monitoring. These upgrades cut turnaround times and improved compliance transparency for global shipments. In recent years, investing in real-time process analytics allowed us to spot deviations sooner, reduce energy intake, and further cut down-hazardous waste at the source.
The way we approach H-imidazo[1,2-a]pyridine-6-carboxylic acid isn’t shaped by marketing slogans or abstract assurances. Each shipment exits the door rooted in the experience of dozens of chemists, batch operators, and engineers—each dedicated to offering not a commodity, but a platform for ambitious work. Consistency across lots, full traceability, and proactive engagement stand as the direct result of treating every gram as a reflection of trust with advanced research clients.
Field-tested solutions—like improved crystallization for rapid filtration, upgrades to drying and packaging, and hands-on technical support—grow not out of theory but daily necessity. Researchers receive both high-purity material and a digital trail supporting regulatory and grant-driven documentation. Candid conversations around route selection, impurity troubleshooting, or alternative building blocks have led to discoveries on both sides of the collaboration table.
Through all this, we maintain focus on providing a material with reliable, clean access to a uniquely reactive scaffold. The chemical and pharmaceutical landscape evolves rapidly, but strong partnerships built around know-how, open exchange, and a willingness to learn carry forward value that transcends individual projects. The story of H-imidazo[1,2-a]pyridine-6-carboxylic acid isn’t one of simple molecules or abstract benchmarks—it’s a shared journey, driving innovation through practical solutions, transparent data, and a commitment to both scientific and operational excellence.